Browse Studies — Arctuva | Arctuva
Arctuva
Browse Studies
About
FAQ
Sign in
Get started
Browse studies
Find your next paid study
1 recruiting study matching your filters
Newest first
Highest paying
Filters
1
Phase 1
An Open-label, Phase I Trial, With an Expansion Cohort: Macrophage Conditioning to Synergize With CAR-T in High-risk Lymphoma (MAC-SHIFT)
Axatilimab + CAR-T in High-Risk Lymphoma
Diffuse Large B Cell Lymphoma (DLBCL)
Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
High-grade B-cell Lymphoma (HGBCL)
+3 more
~
Estimated
~$10 – $6,250
Northside Hospital, Inc.
NCT07638982